Clinical trial
Safety, Efficacy, and Cost-effectiveness of a Reduced Infliximab Infusion Time Protocol
NCT05340764 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Efficacy, and Cost-effectiveness of a Reduced Infliximab Infusion Time Protocol
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 1, 2020
- Completion date
- May 4, 2023
- Enrollment
- 96 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.